- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05514730
Treatment for Problematic Sexual Behavior of Preteen Children
Study Overview
Status
Detailed Description
In 2015, a new intervention, PBT, was designed that relied on the current etiological research on PSB and the state-of-the-science regarding behavior change among children. A small pilot of the protocol yielded positive results. Although the pilot included only 10 participants, statistically significant pre-post changes were observed for general PSB, intrusive forms of sexual behavior, and social modeling of sexuality in the home. Training in PBT was provided to a limited number of practicing clinicians in the state of Texas and program evaluation metrics were included. Pre-post change for general PSB was significant, as were changes for intrusive forms of sexual behavior.
Despite positive outcomes in non-controlled research, it is unclear whether PBT achieves effects larger than might be seen with more general, non-specific forms of intervention. To demonstrate such an effect requires the completion of a randomized controlled trial (RCT). However, a number of feasibility issues must be answered before conducting a large scale, definitive RCT. As such, the current RCT is conceived as a feasibility project to determine the likelihood of successfully recruiting and retaining a sufficient number of participants, to derive comparative effect size estimates between PBT and SAU to inform later power analyses, and to ascertain participant satisfaction with PBT.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Brian Allen, PsyD
- Phone Number: 7175314100
- Email: ballen1@pennstatehealth.psu.edu
Study Locations
-
-
Pennsylvania
-
Harrisburg, Pennsylvania, United States, 17110
- Recruiting
- Penn State Hershey Medical Center-TLC Research and Treatment Center
-
Contact:
- Brian Allen
- Phone Number: 717-531-4100
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Child between ages 4 and 12 years
- Caregiver reports a raw score on the CSBI greater than 4.
- A primary caregiver is willing to participate in treatment.
- Child earns a scaled score above 69 on the Kaufman Brief Intelligence Test (KBIT-2)
- Child proficient in spoken English
- Caregiver proficient in written and spoken English.
Exclusion Criteria:
- Child is less than 4 years of age or older than 12 years of age.
- Caregiver reports a score on the CSBI lower than 4
- A primary caregiver is unwilling to participate in treatment.
- Child scored lower than 70 on the KBIT-2.
- The primary caregiver is suspected of perpetrating child sexual abuse.
- Child not proficient in spoken English.
- Caregiver not proficient in both written and spoken English.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Experimental Treatment
The experimental treatment is Phase-Based Treatment (PBT) for Problematic Sexual Behavior of Preteen Children, an innovative intervention demonstrating promise in preliminary testing.
|
PBT is a skills-based protocol that primarily works with caregivers to manage problematic behavior and to teach children healthy information about sex and sexuality.
It was designed based on the current empirical knowledge regarding the etiology and treatment of childhood problematic sexual behavior.
It is delivered in 12 weekly sessions, with each session lasting approximately 50 minutes.
|
|
Active Comparator: Control Treatment
The Control Treatment will utilize a Treatment-as-Usual (TAU) condition designed to mimic the types of treatment generally provided in the community for mental health concerns of children.
|
The TAU intervention designed for this trial relies largely on the delivery of child-focused treatment techniques, particularly on the development of therapeutic rapport through the utilization of non-directive techniques.
These sessions are supplemented with educational materials for the caregiver on child behavior and parenting recommendations.
This treatment is designed to be administered over 12 weekly sessions, with each session lasting approximately 50 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in scores on the Child Sexual Behavior Inventory (CSBI)
Time Frame: Through study completion, typically 12 weeks.
|
The CSBI is a widely-used measure of problematic sexual behavior among preteen children.
It is completed by caregivers and asks the frequency with which 38 different items were observed over the past six months.
Caregivers report frequency using a 4-point Likert-type scale ranging from 0 (Not at all) to 3 (at least once per week).
|
Through study completion, typically 12 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in scores on the Sexual Concerns subscale of the Trauma Symptom Checklist for Young Children (TSCYC)
Time Frame: Through study completion, typically 12 weeks.
|
The TSCYC is a widely-used measure of various forms of emotional and behavioral concerns that are commonly associated with the experience of a traumatic event.
One subscale, Sexual Concerns, assesses the child's display of sexual behaviors and anxiety around sexual topics.
Scores are reported in T-scores, which have an average of 50 and a standard deviation of 10.
Higher scores indicate greater concerns.
|
Through study completion, typically 12 weeks.
|
|
Change in scores on the Family Sexuality Index (FSI).
Time Frame: Through study completion, typically 12 weeks.
|
The FSI assesses the frequency with which various forms of social modeling of sex occurs in the home.
The FSI is a 14-item measure and each item is answered with a No (0) or Yes (1).
The items are then summed to compute a raw score with higher scores indicating a greater display of sexuality in the home.
|
Through study completion, typically 12 weeks.
|
|
Change in scores on the Conduct Problems subscale of the Strengths and Difficulties Questionnaire (SDQ)
Time Frame: Through study completion, typically 12 weeks.
|
The SDQ is a widely used measure of emotional and behavioral concerns of children.
The Conduct Problems subscale specifically assessing behavioral problems, such as oppositionality, lying, and stealing.
This subscale includes 5 items that are scored on a scale from 0 (Not True) to 2 (Certainly True).
Higher summed scores indicate greater concerns in this area.
|
Through study completion, typically 12 weeks.
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Allen, B., Berliner, L., Shenk, C. E., Bendixsen, B., Zellhoefer, A., Dickmann, C. R., Arnold, B., & Chen, M. J. (2018). Development and pilot testing of a phase-based treatment for preteen children with problematic sexual behavior. Evidence-based Practice in Child and Adolescent Mental Health, 3, 274-285.
- Dickmann, C. R., Zellhoefer, A., Arnold, B., & Allen, B. (2018). Implementing a phase-based treatment for preteen children with problematic sexual behavior: Case examples. Evidence-based Practice in Child and Adolescent Mental Health, 3, 286-293.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- STUDY00020807
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Problematic Sexual Behavior Among Preteen Children
-
Seattle Children's HospitalDoris Duke Charitable FoundationCompletedParenting | Psychosocial Problem | Problematic Behavior in Children
-
Vrije Universiteit BrusselUnknownParent-child Problem | Problematic Behavior in ChildrenBelgium
-
University of CologneGerman Federal Ministry of Education and Research; University of Applied Sciences...UnknownProblematic Behavior in ChildrenGermany
-
New York City Health and Hospitals CorporationCompleted
-
MaineHealthCompletedFood Insecurity | Family Functioning | Nutrition | Family Function | Caregiver Stress | Food Insecurity Among Children | Child Mental Health | Caregiver Distress | Social Emotional Wellness | Caregiver Mental HealthUnited States
-
Sohag UniversityNot yet recruitingEvaluation of Some Puberty-related Hormones Among Children and Adolescents With Chronic Kidney DiseasesEgypt
-
Menoufia UniversityCompletedMonosymptomatic Nocturnal Enuresis | Desmopressin | Nocturnal Enuresis in ChildrenEgypt
-
University of AarhusRecruitingUrinary Incontinence in ChildrenDenmark
-
Duke UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsRecruitingHeart Failure | Pain | Pneumonia | Hypertension | Edema | Hemophilia | Insomnia | Pulmonary Arterial Hypertension | Coagulation Disorder | Asthma in Children | Down Syndrome | Attention Deficit Hyperactivity Disorder | Bronchopulmonary Dysplasia | Hypokalemia | Hyperphosphatemia | Primary Hyperaldosteronism | Adrenal Insufficiency and other conditionsUnited States, Canada
-
Brain Inflammation CollaborativeColumbia University; Solve ME/CFS Initiative; Care EvolutionRecruitingUnhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation ResearchMultiple Sclerosis | Autoimmune Diseases | Anorexia Nervosa | Psoriasis | Bulimia Nervosa | Endometriosis | Celiac Disease | Crohn's Disease | Traumatic Brain Injury | PANDAS | Sjogren's Syndrome | Autoimmune Encephalitis | Psychiatric Disorder | Dysautonomia | Long COVID | Tourette's Syndrome | Inflammatory Bowel Disease... and other conditionsUnited States
Clinical Trials on Phase-based Treatment (PBT) for Problematic Sexual Behavior of Preteen Children
-
Milton S. Hershey Medical CenterCompleted
-
University of California, Los AngelesVirginia Commonwealth University; United States Naval Medical Center, San Diego and other collaboratorsRecruiting
-
University of PittsburghNational Institute of Mental Health (NIMH); University of Michigan; NYU Langone... and other collaboratorsRecruitingAttention Deficit and Disruptive Behavior Disorders | Child Behavior ProblemUnited States
-
Case Comprehensive Cancer CenterTerminatedAny Cancer DiagnosisUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IV Breast Cancer AJCC v8 | Endometrial Carcinoma | Endometrial Endometrioid Adenocarcinoma | Triple-Negative Breast Carcinoma | Stage IV Vulvar Cancer AJCC v8 | Stage III Ovarian Cancer AJCC v8 | Stage IV Ovarian Cancer AJCC v8 | Stage IV Vaginal... and other conditionsUnited States
-
Mayo ClinicCompletedMalignant Solid Neoplasm | Lymphoma | Multiple Myeloma | Hematopoietic and Lymphoid System Neoplasm | Chronic LeukemiaUnited States